Current treatment options and drug delivery systems as potential therapeutic agents for ovarian cancer: a review.
about
Drug Delivery Approaches for the Treatment of Cervical CancerDownregulation of SASH1 correlates with tumor progression and poor prognosis in ovarian carcinoma.Dihydromyricetin Induces Apoptosis and Reverses Drug Resistance in Ovarian Cancer Cells by p53-mediated Downregulation of SurvivinSnail promotes epithelial-mesenchymal transition and invasiveness in human ovarian cancer cells.Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer ModelsUtilising inorganic nanocarriers for gene delivery.Antibody-targeted nanoparticles for cancer treatment.Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study.Nanoparticle as a novel tool in hyperthermic intraperitoneal and pressurized intraperitoneal aerosol chemotheprapy to treat patients with peritoneal carcinomatosis.A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer.
P2860
Q26742026-24467BFB-775D-4B86-B98C-EA9F3A34B8FEQ30008980-57A092D9-EEAB-45A8-BD70-D46B40F882E0Q33594379-5A368F15-CDC7-41A4-B345-13C0C8CB2E56Q35870779-638A42A6-9E1C-4E90-A683-01C136AF3513Q37447340-D8233060-D63C-47F4-8BE1-8017B84F90A7Q38611873-79040A85-19C0-4BD9-8C6B-DB6C5627E3EDQ38887307-208B3576-19C1-493A-B640-AB55B5F2D084Q46871150-F0A81F28-E618-4046-A35C-758EC4D3003BQ47165034-D8342619-1883-4CCD-8FD4-0E223EC4488DQ47861842-C5E10619-0F32-4791-811F-9BAC4C072C89
P2860
Current treatment options and drug delivery systems as potential therapeutic agents for ovarian cancer: a review.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Current treatment options and ...... for ovarian cancer: a review.
@en
type
label
Current treatment options and ...... for ovarian cancer: a review.
@en
prefLabel
Current treatment options and ...... for ovarian cancer: a review.
@en
P1476
Current treatment options and ...... for ovarian cancer: a review.
@en
P2093
Anis Abdul Karim
P304
P356
10.1016/J.MSEC.2014.06.002
P50
P577
2014-06-20T00:00:00Z